Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 851,101
  • Shares Outstanding, K 174,406
  • Annual Sales, $ 82,270 K
  • Annual Income, $ -104,130 K
  • 60-Month Beta 2.48
  • Price/Sales 10.07
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings -0.15 on 11/01/19
  • Next Earnings Date 08/07/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.18
  • Number of Estimates 6
  • High Estimate -0.15
  • Low Estimate -0.20
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +37.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.19 +16.47%
on 06/15/20
5.17 -5.61%
on 06/03/20
-0.25 (-4.87%)
since 06/02/20
3-Month
3.27 +49.24%
on 04/03/20
5.39 -9.46%
on 05/21/20
+1.41 (+40.63%)
since 04/02/20
52-Week
1.95 +150.26%
on 03/19/20
7.07 -30.98%
on 02/14/20
+2.60 (+114.04%)
since 07/02/19

Most Recent Stories

More News
ImmunoGen Presents Preclinical Data on IMGN151 at Virtual AACR Annual Meeting

--Potent Anti-Tumor Activity Exhibited in Ovarian Cancer and Other Tumor Types Regardless of FRa Expression Level

IMGN : 4.88 (+2.74%)
ImmunoGen Announces Virtual 2020 Annual Meeting of Shareholders

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the 2020 Annual Meeting of Shareholders (the "Annual...

IMGN : 4.88 (+2.74%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on May 29, 2020 the compensation committee of the Company's...

IMGN : 4.88 (+2.74%)
ImmunoGen Appoints Stacy Coen as Senior Vice President and Chief Business Officer

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Stacy A. Coen has been appointed Senior Vice President...

IMGN : 4.88 (+2.74%)
Why Is ImmunoGen (IMGN) Up 14.7% Since Last Earnings Report?

ImmunoGen (IMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMGN : 4.88 (+2.74%)
ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin(R) in Recurrent Ovarian Cancer, Regardless of Platinum Status

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced initial data from the FORWARD II study evaluating mirvetuximab...

IMGN : 4.88 (+2.74%)
Thinking about buying stock in CleanSpark, IMV Inc, Canopy Growth Corp, ImmunoGen, or Chesapeake Energy Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSK, IMV, CGC, IMGN, and CHK.

CGC : 16.45 (-0.12%)
CHK : 11.85 (-7.28%)
IMGN : 4.88 (+2.74%)
ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit,...

IMGN : 4.88 (+2.74%)
ImmunoGen to Present Preclinical Data on IMGN151 at AACR Virtual Annual Meeting

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced preclinical data for its next generation anti-folate receptor...

IMGN : 4.88 (+2.74%)
ImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin(R) in Recurrent Ovarian Cancer, Regardless of Platinum Status

--Results to be Presented in an Oral Session at ASCO 2020 Virtual Scientific Program

IMGN : 4.88 (+2.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IMGN with:

Business Summary

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended...

See More

Key Turning Points

2nd Resistance Point 5.09
1st Resistance Point 4.99
Last Price 4.88
1st Support Level 4.75
2nd Support Level 4.61

See More

52-Week High 7.07
Fibonacci 61.8% 5.11
Last Price 4.88
Fibonacci 50% 4.51
Fibonacci 38.2% 3.91
52-Week Low 1.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar